174 related articles for article (PubMed ID: 10534124)
1. Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1).
Fedyk ER; Ryyan DH; Ritterman I; Springer TA
J Leukoc Biol; 1999 Oct; 66(4):667-73. PubMed ID: 10534124
[TBL] [Abstract][Full Text] [Related]
2. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells.
Honczarenko M; Douglas RS; Mathias C; Lee B; Ratajczak MZ; Silberstein LE
Blood; 1999 Nov; 94(9):2990-8. PubMed ID: 10556181
[TBL] [Abstract][Full Text] [Related]
3. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.
D'Apuzzo M; Rolink A; Loetscher M; Hoxie JA; Clark-Lewis I; Melchers F; Baggiolini M; Moser B
Eur J Immunol; 1997 Jul; 27(7):1788-93. PubMed ID: 9247593
[TBL] [Abstract][Full Text] [Related]
4. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
[TBL] [Abstract][Full Text] [Related]
5. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.
Dar A; Kollet O; Lapidot T
Exp Hematol; 2006 Aug; 34(8):967-75. PubMed ID: 16863903
[TBL] [Abstract][Full Text] [Related]
6. Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells.
Dürig J; Rosenthal C; Elmaagacli A; Heyworth C; Halfmeyer K; Kasper C; Novotny J; Dührsen U
Leukemia; 2000 Sep; 14(9):1652-60. PubMed ID: 10995013
[TBL] [Abstract][Full Text] [Related]
7. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
[TBL] [Abstract][Full Text] [Related]
8. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats.
Hatch HM; Zheng D; Jorgensen ML; Petersen BE
Cloning Stem Cells; 2002; 4(4):339-51. PubMed ID: 12626097
[TBL] [Abstract][Full Text] [Related]
9. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion.
Wang JF; Liu ZY; Groopman JE
Blood; 1998 Aug; 92(3):756-64. PubMed ID: 9680341
[TBL] [Abstract][Full Text] [Related]
10. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor.
Honczarenko M; Le Y; Glodek AM; Majka M; Campbell JJ; Ratajczak MZ; Silberstein LE
Blood; 2002 Oct; 100(7):2321-9. PubMed ID: 12239139
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis.
Dutt P; Wang JF; Groopman JE
J Immunol; 1998 Oct; 161(7):3652-8. PubMed ID: 9759889
[TBL] [Abstract][Full Text] [Related]
12. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
13. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
Van Overstraeten-Schlögel N; Beguin Y; Gothot A
Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
[TBL] [Abstract][Full Text] [Related]
14. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors.
Ishii T; Nishihara M; Ma F; Ebihara Y; Tsuji K; Asano S; Nakahata T; Maekawa T
J Immunol; 1999 Oct; 163(7):3612-20. PubMed ID: 10490954
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
Möhle R; Failenschmid C; Bautz F; Kanz L
Leukemia; 1999 Dec; 13(12):1954-9. PubMed ID: 10602415
[TBL] [Abstract][Full Text] [Related]
16. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1.
Arai J; Yasukawa M; Yakushijin Y; Miyazaki T; Fujita S
Eur J Haematol; 2000 May; 64(5):323-32. PubMed ID: 10863978
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin.
Juremalm M; Hjertson M; Olsson N; Harvima I; Nilsson K; Nilsson G
Eur J Immunol; 2000 Dec; 30(12):3614-22. PubMed ID: 11169404
[TBL] [Abstract][Full Text] [Related]
19. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
Möhle R; Bautz F; Rafii S; Moore MA; Brugger W; Kanz L
Blood; 1998 Jun; 91(12):4523-30. PubMed ID: 9616148
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells.
Corcione A; Ottonello L; Tortolina G; Facchetti P; Airoldi I; Guglielmino R; Dadati P; Truini M; Sozzani S; Dallegri F; Pistoia V
J Natl Cancer Inst; 2000 Apr; 92(8):628-35. PubMed ID: 10772680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
